Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$21.22 - $25.7 $2,037 - $2,467
-96 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$22.86 - $30.95 $2,194 - $2,971
96 New
96 $2,000
Q1 2021

Apr 29, 2021

SELL
$24.58 - $42.82 $270 - $471
-11 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$32.95 - $50.25 $362 - $552
11 New
11 $1,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.